AI Verdict
IGC has stronger fundamentals based on our AI analysis.
IGC vs IEP Fundamental Comparison
| Metric | IGC | IEP |
|---|---|---|
| Revenue | $519,000.0 | $9.7B |
| Net Income | $-3.4M | $-299.0M |
| Net Margin | -659.0% | -3.1% |
| ROE | -42.3% | -5.3% |
| ROA | -35.1% | -2.1% |
| Current Ratio | 1.32x | N/A |
| Debt/Equity | 0.02x | 0.00x |
| EPS | $-0.04 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IGC vs IEP: Frequently Asked Questions
Is IGC or IEP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IGC has stronger fundamentals. IGC is rated STRONG SELL (85% confidence) while IEP is rated STRONG SELL (82% confidence). This is not investment advice.
How does IGC compare to IEP fundamentally?
IGC Pharma, Inc. has ROE of -42.3% vs ICAHN ENTERPRISES L.P.'s -5.3%. Net margins are -659.0% vs -3.1% respectively.
Which stock pays higher dividends, IGC or IEP?
IGC has a dividend yield of N/A or no dividend while IEP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IGC or IEP for long term?
For long-term investing, consider that IGC has STRONG SELL rating with 85% confidence, while IEP has STRONG SELL rating with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IGC vs IEP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IGC vs IEP, the AI consensus favors IGC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.